iBio
IBIO
#9537
Rank
NZ$0.12 B
Marketcap
NZ$3.58
Share price
-2.79%
Change (1 day)
-54.76%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.64. an increase over its 2024 EPS that were of NZ-$11.13.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ-$3.00-73.08%
2024NZ-$11.13-93.88%
2023NZ-$181.89-8.14%
2022NZ-$198.0192.67%
2021NZ-$102.77-80.33%
2020NZ-$522.43-35.11%
2019NZ-$805.06-38.96%
2018NZ-$1,319-6.1%
2017NZ-$1,40536.67%
2016NZ-$1,02833.33%
2015NZ-$770.8150%
2014NZ-$513.87-53.85%
2013NZ-$1,113-7.14%
2012NZ-$1,199-64.1%
2011NZ-$3,34077.27%
2010NZ-$1,884144.44%
2009NZ-$770.8112.93%
2008NZ-$682.5712.2%
2007NZ-$608.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.08-823.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ-$0.89-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.65 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.42-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA